Skip to main content
medichelpline
Join Free
Back to Drug Index
AntidiabeticsSUBCUTANEOUSStandard

ADMELOG SOLOSTAR

INSULIN LISPRO

Standard Dose
300 UNITS/3ML (100 UNITS/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription

Key Takeaways

  • Primary indication: Review priority: STANDARD Marketing status: Prescription
  • Approval overview ADMELOG SOLOSTAR is listed in Drugs@FDA under application 209196 (BLA).
  • Review priority: STANDARD Marketing status: Prescription Active ingredient INSULIN LISPRO Form and strength SOLUTION;SUBCUTANEOUS - 300 UNITS/3ML (100 UNITS/ML) Sponsor SANOFI-AVENTIS US Submission history Latest submission status date: 2023-08-31 00:00:00.

Structured Monograph

Clinical summary

Approval overview ADMELOG SOLOSTAR is listed in Drugs@FDA under application 209196 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient INSULIN LISPRO Form and strength SOLUTION;SUBCUTANEOUS - 300 UNITS/3ML (100 UNITS/ML) Sponsor SANOFI-AVENTIS US Submission history Latest submission status date: 2023-08-31 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.